Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-30

FDA Approved: FLUVOXAMINE MALEATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' original application for a generic fluvoxamine maleate product, expanding access to this SSRI for obsessive-compulsive diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

ORIG AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)